Gliclapack MV 0.2mg/500mg/80mg Tablet

Gliclapack MV 0.2mg/500mg/80mg Tablet is used to lower blood glucose level in patients with Type 2 Diabetes Mellitus, especially when other medicines are not able to provide the desired results. It belongs to a group of medicines known as alpha-glucosidases inhibitors.

This medication is used to control diabetes; it is not a cure. Other components of treatment plan are important: follow prescribed diet, medication, and exercise regimen. Take exactly as directed; with meal(s) at the same time each day.

Do not change dose or discontinue without consulting prescriber. Avoid alcohol while taking this medication; could cause severe reaction. Inform prescriber of all other prescription or OTC medications you are taking; do not introduce new medication without consulting prescriber.

Do not take other medication within 2 hours of this medication unless so advised by prescriber. Maintain regular dietary intake and exercise routine and always carry quick source of sugar with you.

You may experience side effects during first weeks of therapy (headache, nausea); consult prescriber if these persist. Report severe or persistent side effects, extended vomiting or flu-like symptoms, skin rash, easy bruising or bleeding, or change in color of urine or stool.

Read more: Type 1 Diabetes

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

• Type 2 Diabetes Mellitus

  Gliclapack MV 0.2mg/500mg/80mg Tablet is used to control blood sugar levels in type II diabetes mellitus either individually or in combination with other medicines.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

• Allergy

• Intestinal Obstruction

• Digestive Disorders

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

• Diarrhoea

• Flatulence

• Pneumatosis Intestinalis

• Abnormal Liver Function

• Nausea Or Vomiting

• Dizziness

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

• How long is the duration of effect?

  The duration for which action of this medicine is not clinically established.

• What is the onset of action?

  The time taken for the onset of action is not clinically established.

• Are there any pregnancy warnings?

  Use of this medicine is not recommended during pregnancies as the possible effect on developing fetus is unknown. It is recommended to discontinue the consumption of this medicine if you are pregnant or planning to become pregnant. Consult your doctor before stopping the use of this medication so that an alternate medication can be prescribed.

• Is it habit forming?

  No habit forming tendencies were reported.

• Are there any breast-feeding warnings?

  Use of this medicine is not recommended for use by breastfeeding mothers as the effect on the infant is not clinically established. Consult your doctor so that an alternate medicine can be prescribed.

• Is It safe with alcohol?

  It is unsafe to consume alcohol along with this medicine.

• Is it safe to drive while on this medicine?

  This medicine usually does not affect the alertness and thus patients ability to drive.

• Does this affect kidney function?

  Caution must be taken using this medicine in patients with kidney disease. Adjustment of dose might be needed. Kindly consult with your doctor before taking it.

• Does this affect liver function?

  Limited information is available regarding its use in patients with kidney disease. Kindly consult your doctor before taking this medicine.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Gliclapack MV 0.2mg/500mg/80mg Tablet , and hence can be used as its substitute.

• Cyblex Mv 80.2 Tablet

  Eris Life Sciences Pvt Ltd

• Glz Trio Tablet

  Alembic Pharmaceuticals Ltd

• Vogli Trio 0.2 Tablet

  Medley Pharmaceuticals

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

• Are there any missed dose instructions?

  Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for the next scheduled dose.

• Are there any overdose instructions?

  Contact your doctor immediately if an overdose is suspected.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

• India

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

This medication works by selectively inhibits α-glucosidase in the intestinal wall, delaying the digestion and absorption of carbohydrates, thereby preventing a sudden rise in blood glucose levels after food.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Diabetologist before using this medicine.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Alcohol

  Alcohol

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Interaction with Lab Test

  Lab

  Information not available.

• Interaction with Medicine

  Insulin

  Gliclapack MV 0.2mg/500mg/80mg Tablet should be taken with caution when used along with other medications used for lowering blood glucose. Special precaution including monitoring of blood glucose level is advised in such cases.

• Interaction with Disease

  Diabetic Ketoacidosis

  Report the incidence of Acidosis to the doctor. Suitable dosage adjustment and safety monitoring are advised in mild cases. However, if the acidosis is severe, then it is not recommended for use.

• Interaction with Food

  Food

  Information not available.

• Ques : What is Gliclapack MV 0.2mg/500mg/80mg Tablet used for?

  Ans : Gliclapack MV 0.2mg/500mg/80mg Tablet is used to lower blood glucose level in patients with Type 2 Diabetes Mellitus, especially when other medicines are not able to provide the desired results.

• Ques : Where is Gliclapack MV 0.2mg/500mg/80mg Tablet approved?

  Ans : Gliclapack MV 0.2mg/500mg/80mg Tablet is approved in India and Japan.

• Ques : Should Gliclapack MV 0.2mg/500mg/80mg Tablet be taken with a meal or without a meal?

  Ans : Gliclapack MV 0.2mg/500mg/80mg Tablet should be taken with a meal for better effectiveness.

• Ques : Is Gliclapack MV 0.2mg/500mg/80mg Tablet safe for usage in paediatrics?

  Ans : Gliclapack MV 0.2mg/500mg/80mg Tablet is not recommended for usage in paediatrics as its safety and effectiveness are not known.

• Ques : Is Gliclapack MV 0.2mg/500mg/80mg Tablet safe for usage in patients with gastrointestinal disorders?

  Ans : Gliclapack MV 0.2mg/500mg/80mg Tablet should be used with care in patients with gastrointestinal disorders as it may worsen the health condition.

• Ques : What are the dietary restrictions while taking Gliclapack MV 0.2mg/500mg/80mg Tablet?

  Ans : There are no specific dietary restrictions while taking Gliclapack MV 0.2mg/500mg/80mg Tablet unless the doctor instructs otherwise.

• Voglibose-Drug Information portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 10 May 2022]. Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/voglibose

• Voglibose-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 10 May 2022]. Available from:

  https://go.drugbank.com/drugs/DB04878